Skip to main content

. 1954 Mar;9(1):91–94. doi: 10.1111/j.1476-5381.1954.tb00822.x

Pharmacology of the porphyrins and porphobilinogen

A Goldberg, W D M Paton, J W Thompson

PMCID: PMC1509378 PMID: 13149782

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

FALK J. E., DRESEL E. I., RIMINGTON C. Porphobilinogen as a porphyrin precursor, and interconversion of porphyrins, in a tissue system. Nature. 1953 Aug 15;172(4372):292–294. doi: 10.1038/172292a0. [DOI] [PubMed] [Google Scholar]
Prunty F. T. Acute porphyria: Some properties of porphobilinogen. Biochem J. 1945;39(5):446–451. doi: 10.1042/bj0390446. [DOI] [PMC free article] [PubMed] [Google Scholar]
Supniewski J. V. The action of visible light on the haematoporphyrin sensitised organs. J Physiol. 1927 Oct 5;64(1):30–38. doi: 10.1113/jphysiol.1927.sp002416. [DOI] [PMC free article] [PubMed] [Google Scholar]
WEHRMACHER W. H. New symptomatic treatment for acute intermittent porphyria. AMA Arch Intern Med. 1952 Jan;89(1):111–114. doi: 10.1001/archinte.1952.00240010121012. [DOI] [PubMed] [Google Scholar]
WESTALL R. G. Isolation of porphobilinogen from the urine of a patient with acute porphyria. Nature. 1952 Oct 11;170(4328):614–616. doi: 10.1038/170614a0. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES